Satish Mocherla is an Infectious Disease physician. OpenAlex indexes 7 publications with 226 citations (h-index 5); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6560 Fannin St
Ste 1540, Tmh Physician Associates
Houston, TX 770302761
Telephone
713-799-9997Provider last certified this registry record 23 Feb 2026.
Clinical trials
- Atovaquone for Treatment of COVID-19
Sponsor: University of Texas Southwestern Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20242 payments
- Gilead Sciences, Inc.Program year20221 payment
- ViiV Healthcare CompanyProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
45%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor17.1%Descovy65%Triumeq35%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor14.5%Tivicay79%Isentress21%Part D<11 patients+ 2 more classes in this area
Cardiovascular
23.9%Statin7.6%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker6.9%Amlodipine Besylate100%Part D<11 patients+ 2 more classes in this area
Nervous system
14.7%SSRI9.2%Trazodone Hcl67%Sertraline Hcl33%Part D<11 patientsGabapentinoids5.5%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Disseminated Nocardiosis Associated with Treatment with Infliximab in a Patient with Ulcerative Colitis
American Journal of Case Reports
2017 - Drug-induced leukocytoclastic vasculitis: tigecycline a rare cause
The Southwest Respiratory and Critical Care Chronicles
2015 - Abdominal actinomycosis: A report on two cases of acute bowel obstruction in males
American Medical Student Research Journal
2015 - Mycobacterium abscessus: a rare cause of vascular graft infection
Scandinavian Journal of Infectious Diseases
2014
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”